PA21 Phase II Clinical Study in Hemodialysis Patients With Hyperphosphatemia

Clinical trial NCT01521494 · COMPLETED

Trial details

NCT number: NCT01521494
Sponsor: Kissei Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Kidney Disease Requiring Hemodialysis

Start date: 2012-01-11
Primary completion: 2012-07-03
Enrollment: 183

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.